Author: Bouic, Patrick J. D.
Similar Items: Pharmacokinetics and dosing rationale of Para-Aminosalicylic acid in children and the evaluation of the in vitro metabolism of Ethionamide, Terizidone and Para-aminosalicylic acid
- Pharmacokinetics of twice-daily versus once-daily dosing with granular slow-release para-aminosalicylic acid in adults on second-line anti-tuberculosis and antiretroviral treatment
- Pharmacokinetic study of anti-tb drug para-aminosalicylic acid and its metabolites: a possible relationship with the development of toxicity
- Pharmacokinetics and safety of first -- and second--line anti-- tuberculosis drugs in children
- An analytical investigation of the physiochemical properties of crushed rifapentine administered to paediatrics.
- Addressing critical knowledge gaps to improve and shorten multidrug-resistant tuberculosis treatment regimens in children
- And therapeutic outcomes lopinavir-ritonavir and a rifampicin containing anti-tuberculosis pharmacokinetics in children with tuberculosis/hiv co-infection treated with regimen